AAPL339.75+0.77 (+0.23%) ▲|ABBV265.21+0.73 (+0.28%) ▲|ABT103.69+0.71 (+0.69%) ▲|ACN183.72-2.39 (-1.28%) ▼|ADBE238.25-11.27 (-4.52%) ▼|AMAT472.46+8.22 (+1.77%) ▲|AMD623.77+8.25 (+1.34%) ▲|AMGN410.24+17.08 (+4.34%) ▲|AMT175.25+0.65 (+0.37%) ▲|AMZN254.98-3.47 (-1.34%) ▼|AVGO364.54+1.88 (+0.52%) ▲|AXP305.07-8.52 (-2.72%) ▼|BA197.72-3.43 (-1.71%) ▼|BAC56.20-1.76 (-3.04%) ▼|BKNG164.22-4.30 (-2.55%) ▼|BLK1,066.66-23.61 (-2.17%) ▼|BMY62.25-0.37 (-0.59%) ▼|BNY150.17-3.72 (-2.42%) ▼|BRK-B503.49+1.48 (+0.29%) ▲|C132.47-2.58 (-1.91%) ▼|CAT808.01-8.49 (-1.04%) ▼|CL87.05+0.79 (+0.92%) ▲|CMCSA22.42-0.51 (-2.22%) ▼|COF200.55-4.37 (-2.13%) ▼|COP125.27-2.26 (-1.77%) ▼|COST899.41+0.93 (+0.10%) ▲|CRM233.28-3.14 (-1.33%) ▼|CSCO106.44-5.02 (-4.50%) ▼|CVS87.10-0.50 (-0.57%) ▼|CVX202.41-1.26 (-0.62%) ▼|DE703.12+18.39 (+2.69%) ▲|DHR221.09+5.25 (+2.43%) ▲|DIS103.82-0.41 (-0.39%) ▼|DUK116.31-0.43 (-0.37%) ▼|EMR154.19+2.47 (+1.63%) ▲|FDX295.94+0.15 (+0.05%) ▲|GD343.39-10.51 (-2.97%) ▼|GE319.22+0.21 (+0.07%) ▲|GEV950.28+4.06 (+0.43%) ▲|GILD152.67+2.11 (+1.40%) ▲|GM83.45-0.50 (-0.60%) ▼|GOOG347.41-3.46 (-0.99%) ▼|GOOGL351.16-3.81 (-1.07%) ▼|GS949.49-9.90 (-1.03%) ▼|HD305.35+8.15 (+2.74%) ▲|HON211.85+5.37 (+2.60%) ▲|IBM231.38-0.55 (-0.24%) ▼|INTC123.86+2.08 (+1.71%) ▲|INTU292.35-11.77 (-3.87%) ▼|ISRG402.09+0.44 (+0.11%) ▲|JNJ269.19-0.28 (-0.10%) ▼|JPM340.00-12.04 (-3.42%) ▼|KO88.61+1.49 (+1.71%) ▲|LIN464.91+7.41 (+1.62%) ▲|LLY1,170.14+5.25 (+0.45%) ▲|LMT522.34-13.06 (-2.44%) ▼|LOW196.08+5.10 (+2.67%) ▲|LRCX310.96+8.68 (+2.87%) ▲|MA555.89-11.76 (-2.07%) ▼|MCD250.35+2.47 (+1.00%) ▲|MDLZ61.08+0.91 (+1.51%) ▲|MDT90.77-0.98 (-1.07%) ▼|META736.60-4.65 (-0.63%) ▼|MMM169.30+4.33 (+2.62%) ▲|MO68.64+0.11 (+0.16%) ▲|MRK150.91+1.41 (+0.94%) ▲|MS200.18-5.94 (-2.88%) ▼|MSFT498.00-3.61 (-0.72%) ▼|MU1,096.16+52.20 (+5.00%) ▲|NEE79.26-0.37 (-0.46%) ▼|NFLX72.16-1.20 (-1.64%) ▼|NKE36.10+0.00 (+0.00%) ▲|NOW137.00-0.68 (-0.49%) ▼|NVDA228.87+1.49 (+0.66%) ▲|ORCL149.20+0.64 (+0.43%) ▲|PEP131.19+1.60 (+1.23%) ▲|PFE27.93+0.19 (+0.68%) ▲|PG148.22+2.14 (+1.47%) ▲|PLTR184.99+1.92 (+1.05%) ▲|PM190.23+2.75 (+1.47%) ▲|QCOM198.27+4.04 (+2.08%) ▲|RTX190.99-3.35 (-1.72%) ▼|SBUX95.11+0.21 (+0.22%) ▲|SCHW100.35-6.53 (-6.11%) ▼|SO85.15-0.31 (-0.36%) ▼|SPG205.95+0.97 (+0.47%) ▲|T25.10-0.35 (-1.38%) ▼|TMO658.52-0.24 (-0.04%) ▼|TMUS162.41-2.86 (-1.73%) ▼|TSLA378.90+3.69 (+0.98%) ▲|TXN271.41+0.54 (+0.20%) ▲|UBER69.89-0.95 (-1.34%) ▼|UNH372.95-4.61 (-1.22%) ▼|UNP274.41+4.78 (+1.77%) ▲|UPS95.87+1.12 (+1.18%) ▲|USB59.44-1.00 (-1.65%) ▼|V362.04-7.91 (-2.14%) ▼|VZ46.45-1.23 (-2.58%) ▼|WFC83.15-3.39 (-3.92%) ▼|WMT110.12+2.68 (+2.49%) ▲|XOM158.71+0.41 (+0.26%) ▲|AAPL339.75+0.77 (+0.23%) ▲|ABBV265.21+0.73 (+0.28%) ▲|ABT103.69+0.71 (+0.69%) ▲|ACN183.72-2.39 (-1.28%) ▼|ADBE238.25-11.27 (-4.52%) ▼|AMAT472.46+8.22 (+1.77%) ▲|AMD623.77+8.25 (+1.34%) ▲|AMGN410.24+17.08 (+4.34%) ▲|AMT175.25+0.65 (+0.37%) ▲|AMZN254.98-3.47 (-1.34%) ▼|AVGO364.54+1.88 (+0.52%) ▲|AXP305.07-8.52 (-2.72%) ▼|BA197.72-3.43 (-1.71%) ▼|BAC56.20-1.76 (-3.04%) ▼|BKNG164.22-4.30 (-2.55%) ▼|BLK1,066.66-23.61 (-2.17%) ▼|BMY62.25-0.37 (-0.59%) ▼|BNY150.17-3.72 (-2.42%) ▼|BRK-B503.49+1.48 (+0.29%) ▲|C132.47-2.58 (-1.91%) ▼|CAT808.01-8.49 (-1.04%) ▼|CL87.05+0.79 (+0.92%) ▲|CMCSA22.42-0.51 (-2.22%) ▼|COF200.55-4.37 (-2.13%) ▼|COP125.27-2.26 (-1.77%) ▼|COST899.41+0.93 (+0.10%) ▲|CRM233.28-3.14 (-1.33%) ▼|CSCO106.44-5.02 (-4.50%) ▼|CVS87.10-0.50 (-0.57%) ▼|CVX202.41-1.26 (-0.62%) ▼|DE703.12+18.39 (+2.69%) ▲|DHR221.09+5.25 (+2.43%) ▲|DIS103.82-0.41 (-0.39%) ▼|DUK116.31-0.43 (-0.37%) ▼|EMR154.19+2.47 (+1.63%) ▲|FDX295.94+0.15 (+0.05%) ▲|GD343.39-10.51 (-2.97%) ▼|GE319.22+0.21 (+0.07%) ▲|GEV950.28+4.06 (+0.43%) ▲|GILD152.67+2.11 (+1.40%) ▲|GM83.45-0.50 (-0.60%) ▼|GOOG347.41-3.46 (-0.99%) ▼|GOOGL351.16-3.81 (-1.07%) ▼|GS949.49-9.90 (-1.03%) ▼|HD305.35+8.15 (+2.74%) ▲|HON211.85+5.37 (+2.60%) ▲|IBM231.38-0.55 (-0.24%) ▼|INTC123.86+2.08 (+1.71%) ▲|INTU292.35-11.77 (-3.87%) ▼|ISRG402.09+0.44 (+0.11%) ▲|JNJ269.19-0.28 (-0.10%) ▼|JPM340.00-12.04 (-3.42%) ▼|KO88.61+1.49 (+1.71%) ▲|LIN464.91+7.41 (+1.62%) ▲|LLY1,170.14+5.25 (+0.45%) ▲|LMT522.34-13.06 (-2.44%) ▼|LOW196.08+5.10 (+2.67%) ▲|LRCX310.96+8.68 (+2.87%) ▲|MA555.89-11.76 (-2.07%) ▼|MCD250.35+2.47 (+1.00%) ▲|MDLZ61.08+0.91 (+1.51%) ▲|MDT90.77-0.98 (-1.07%) ▼|META736.60-4.65 (-0.63%) ▼|MMM169.30+4.33 (+2.62%) ▲|MO68.64+0.11 (+0.16%) ▲|MRK150.91+1.41 (+0.94%) ▲|MS200.18-5.94 (-2.88%) ▼|MSFT498.00-3.61 (-0.72%) ▼|MU1,096.16+52.20 (+5.00%) ▲|NEE79.26-0.37 (-0.46%) ▼|NFLX72.16-1.20 (-1.64%) ▼|NKE36.10+0.00 (+0.00%) ▲|NOW137.00-0.68 (-0.49%) ▼|NVDA228.87+1.49 (+0.66%) ▲|ORCL149.20+0.64 (+0.43%) ▲|PEP131.19+1.60 (+1.23%) ▲|PFE27.93+0.19 (+0.68%) ▲|PG148.22+2.14 (+1.47%) ▲|PLTR184.99+1.92 (+1.05%) ▲|PM190.23+2.75 (+1.47%) ▲|QCOM198.27+4.04 (+2.08%) ▲|RTX190.99-3.35 (-1.72%) ▼|SBUX95.11+0.21 (+0.22%) ▲|SCHW100.35-6.53 (-6.11%) ▼|SO85.15-0.31 (-0.36%) ▼|SPG205.95+0.97 (+0.47%) ▲|T25.10-0.35 (-1.38%) ▼|TMO658.52-0.24 (-0.04%) ▼|TMUS162.41-2.86 (-1.73%) ▼|TSLA378.90+3.69 (+0.98%) ▲|TXN271.41+0.54 (+0.20%) ▲|UBER69.89-0.95 (-1.34%) ▼|UNH372.95-4.61 (-1.22%) ▼|UNP274.41+4.78 (+1.77%) ▲|UPS95.87+1.12 (+1.18%) ▲|USB59.44-1.00 (-1.65%) ▼|V362.04-7.91 (-2.14%) ▼|VZ46.45-1.23 (-2.58%) ▼|WFC83.15-3.39 (-3.92%) ▼|WMT110.12+2.68 (+2.49%) ▲|XOM158.71+0.41 (+0.26%) ▲|

14.8 C

New York

Wednesday, September 23, 2026

ROSEN, A LEADING LAW FIRM, Encourages York Space Systems Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – YSS

Early Warning Press Release – FirstLine Venture Partners Corporation Announces Acquisition of Securities of Forward Water Technologies Corp.

DEWALT® Releases Survey About How Next Generation of Workers Perceive Skilled Careers

Tag: risk

Emollient Market worth $4.08 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., June 23, 2025 /PRNewswire/ -- The report "Emollient Market by Type (Esters, Fatty Alcohols, Fatty Acids, Ethers, Silicones, and Other Types), Form...

Emollient Market worth $4.08 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., June 23, 2025 /PRNewswire/ -- The report "Emollient Market by Type (Esters, Fatty Alcohols, Fatty Acids, Ethers, Silicones, and Other Types), Form...

Kiwetinohk announces formal business strategy review

CALGARY, AB, June 23, 2025 /CNW/ - Kiwetinohk Energy Corp. (TSX: KEC) ("Kiwetinohk" or the "Company") announces that it has launched a formal business strategy...

Cruising into the Future: Carnival Cruise Line Selects DXC Technology to Power Technology Infrastructure

ASHBURN, Va., June 23, 2025 /CNW/ - DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, and Carnival Cruise Line, the...

E-Invoicing Could Unlock $116 Billion for the U.S. Economy & $616 Billion Globally, Avalara Finds

New global research from Avalara and Cebr reveals the transformative power of electronic invoicing adoption in the U.S. and across five other major markets...

E-Invoicing Could Unlock Nearly £9 Billion for the UK Economy, Avalara Finds

New global research from Avalara and Cebr reveals the transformative power of electronic invoicing adoption in the UK and across five other major marketsProductivity...

European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)

REYKJAVIK, Iceland and LONDON, June 23, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human use (CHMP) adopted a positive opinion recommending approval for AVT06, Alvotech’s proposed biosimilar to Eylea® (aflibercept 2 mg). Based on a positive recommendation by CHMP, biosimilar medicines can be approved by the European Commission for marketing in the European Economic Area, that includes the 27 member states of the European Union, in addition to Norway, Iceland and Lichtenstein.

European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)

REYKJAVIK, ICELAND and LONDON, UK (June 23, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human use (CHMP) adopted a positive opinion recommending approval for AVT06, Alvotech’s proposed biosimilar to Eylea® (aflibercept 2 mg). Based on a positive recommendation by CHMP, biosimilar medicines can be approved by the European Commission for marketing in the European Economic Area, that includes the 27 member states of the European Union, in addition to Norway, Iceland and Lichtenstein.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsRisk

ROSEN, A LEADING LAW FIRM, Encourages York Space Systems Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – YSS

Early Warning Press Release – FirstLine Venture Partners Corporation Announces Acquisition of Securities of Forward Water Technologies Corp.

DEWALT® Releases Survey About How Next Generation of Workers Perceive Skilled Careers

Tag: risk

Emollient Market worth $4.08 billion by 2030 – Exclusive Report by MarketsandMarkets™

Emollient Market worth $4.08 billion by 2030 – Exclusive Report by MarketsandMarkets™

Kiwetinohk announces formal business strategy review

Cruising into the Future: Carnival Cruise Line Selects DXC Technology to Power Technology Infrastructure

E-Invoicing Could Unlock $116 Billion for the U.S. Economy & $616 Billion Globally, Avalara Finds

E-Invoicing Could Unlock Nearly £9 Billion for the UK Economy, Avalara Finds

European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)

European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)

Huawei Digital Power Hosts the Grid Forming & ESS Safety Forum for Innovative Business Strategies and Safety Ecosystem

Evaluating Income Strategies to Enhance Social Security in Retirement Plans

Huawei Digital Power Hosts the Grid Forming & ESS Safety Forum for Innovative Business Strategies and Safety Ecosystem

IUAV UNIVERSITY OF VENICE LAUNCHES THE WATER LAB: THREE NEW MASTER’S PROGRAMMES FOR FUTURE ENGINEERS AND PLANNERS

Deepcoin Integrates TradingView Webhook for Automated Perpetual Trading Execution

Unleash Your Inner Investor: Jessie Harper’s Take on Tesla’s Potential

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us